Related Experiment Video
Updated: Dec 18, 2025

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
Characteristics of Liver Function in Patients With SARS-CoV-2 and Chronic HBV Coinfection
Xiaojing Zou1, Minghao Fang1, Shusheng Li1
1Department of Emergency, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Insights
COVID-19 patients with chronic hepatitis B virus (HBV) coinfection frequently experienced liver injury, which was linked to severe disease and worse outcomes. Frequent liver function monitoring is crucial for these patients.
Area of Science:
- Hepatology
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19) poses a significant global health challenge.
- Hepatitis B virus (HBV) infection is a prevalent chronic condition worldwide.
- Understanding the interplay between SARS-CoV-2 and chronic HBV is critical for patient management.
Purpose of the Study:
- To characterize liver function abnormalities in patients coinfected with SARS-CoV-2 and chronic HBV.
- To investigate the association between liver dysfunction and COVID-19 severity and prognosis in this coinfected population.
Main Methods:
- A cohort of 105 adult patients with SARS-CoV-2 and chronic HBV coinfection was studied.
- Demographic, clinical, laboratory, treatment, and outcome data were collected.
- Liver function tests and their correlation with disease severity and prognosis were analyzed.
Main Results:
- Elevated liver enzymes and bilirubin were observed in a significant proportion of patients at admission and increased during hospitalization.
- 13.33% of patients developed liver injury, with 28.57% progressing to acute-on-chronic liver failure.
- Liver injury was associated with a higher incidence of severe COVID-19, complications, and increased mortality.
Conclusions:
- Liver injury in SARS-CoV-2/chronic HBV coinfected patients is linked to disease severity and poor prognosis.
- Close monitoring and frequent evaluation of liver function are essential during COVID-19 treatment for patients with chronic HBV.
Background & Aims:
Coronavirus disease 2019 (COVID-19) is a major global health threat. We aimed to describe the characteristics of liver function in patients with SARS-CoV-2 and chronic hepatitis B virus (HBV) coinfection.
Methods:
We enrolled all adult patients with SARS-CoV-2 and chronic HBV coinfection admitted to Tongji Hospital from February 1 to February 29, 2020. Data of demographic, clinical characteristics, laboratory tests, treatments, and clinical outcomes were collected. The characteristics of liver function and its association with the severity and prognosis of disease were described.
Results:
Of the 105 patients with SARS-CoV-2 and chronic HBV coinfection, elevated levels of liver test were observed in several patients at admission, including elevated levels of alanine aminotransferase (22, 20.95%), aspartate aminotransferase (29, 27.62%), total bilirubin (7, 6.67%), gamma-glutamyl transferase (7, 6.67%), and alkaline phosphatase (1, 0.95%). The levels of the indicators mentioned above increased substantially during hospitalization (all P < .05). Fourteen (13.33%) patients developed liver injury. Most of them (10, 71.43%) recovered after 8 (range 6-21) days. Notably the other, 4 (28.57%) patients rapidly progressed to acute-on-chronic liver failure. The proportion of severe COVID-19 was higher in patients with liver injury (P = .042). Complications including acute-on-chronic liver failure, acute cardiac injury and shock happened more frequently in patients with liver injury (all P < .05). The mortality was higher in individuals with liver injury (28.57% vs 3.30%, P = .004).
Conclusion:
Liver injury in patients with SARS-CoV-2 and chronic HBV coinfection was associated with severity and poor prognosis of disease. During the treatment of COVID-19 in chronic HBV-infected patients, liver function should be taken seriously and evaluated frequently.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...

